Ñî¹óåú´«Ã½Ò•îl

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • Ñî¹óåú´«Ã½Ò•îl Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Nov 2 2021

Full Issue

Different Takes: Public Needs More Trust In Drug Companies; Examining The Future of SB 8

Editorial pages weigh in on pharmaceutical companies, advanced practice providers and SB 8.

Drugmaker Merck just shared stunning data on molnupiravir, an oral antiviral it developed to combat COVID-19. In molnupiravir’s phase three clinical trial, it cut COVID-19 patients’ risk of being hospitalized or dying by 50%. The company is now seeking emergency use authorization from the Food and Drug Administration. (Craig Garthwaite, 11/1)

After oral arguments in two cases involving the Texas abortion law Monday morning, it appears that a majority of the justices will rightly say that if a state adopts an unconstitutional law, there must be some way to challenge it in federal court and have it enjoined. (Erwin Chemerinsky, 11/1)

The U.S. Supreme Court heard arguments Monday on whether to allow a Justice Department suit to proceed against Texas' near ban on abortion after six weeks of pregnancy. The final outcome is pivotal not only to women's basic right to an abortion but also to sanctioning an unwelcome new era of citizen law enforcement. The Texas law empowers private citizens, rather than the government, to enforce the ban. It allows private citizens to bring civil litigation against providers or anyone who helps a woman access an abortion after six weeks. The $10,000 bounty creates a Wild West approach to law enforcement that will only further widen the nation's political divide. (11/1)

The Supreme Court listened to arguments on Monday about SB-8, the Texas bill that all but bans abortions after six weeks of pregnancy. That's before most women know they're pregnant. The Texas law is in direct conflict with Supreme Court rulings such as Roe v. Wade and Planned Parenthood v. Casey, which established and reaffirmed that a woman's right to decide what happens to her body during a pregnancy stems from the constitutionally protected right to privacy. (Carli Pierson, 11/1)

On Monday, the Supreme Court heard oral arguments in a challenge to the notorious Texas abortion law, which has effectively banned all abortions in the state later than six weeks after a woman’s last period. And although five conservative justices allowed that law to go into effect two months ago, the arguments Monday suggested that Justices Brett M. Kavanaugh and Amy Coney Barrett might be having something resembling a change of heart. (Paul Waldman, 11/1)

During PA school and early in my career, balancing multiple projects or passions has required me to be as efficient as possible, and that work ethic has continued with me to this day. Once I set a goal, my first step is to prioritize it based on the level of impact and the effort required. I live off to-do lists, so once its prioritized and makes the list, I will do everything in my power to check it off. (Clair Kuriakose, 11/2)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, June 2
  • Monday, June 1
  • Friday, May 29
  • Thursday, May 28
  • Wednesday, May 27
  • Tuesday, May 26
More Morning Briefings
RSS Feeds
  • Ñî¹óåú´«Ã½Ò•îl
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF